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Abstract
We show that hypoxia inducible factor 2a (HIF2a) is highly expressed in patients with pulmonary hypertension (PH). HIF2a is
expressed in every patient with congenital diaphragmatic hernia, while only half of the controls express HIF2a. Our data suggest
that HIF2a is a link between hypoxia and the development of PH.
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Introduction
Idiopathic pulmonary hypertension in newborns (PHN) is
a life-threatening condition and requires intensive clinical
support.1,2 PHN is frequently associated with congenital
disorders, such as congenital heart diseases and congeni-
tal diaphragmatic hernia (CDH).2 The underlying causes
of PHN are still largely unknown, although several poten-
tial genetic and epigenetic mechanisms have been
described.2,3 Prolonged exposure to hypoxia causes pul-
monary arterial hypertension (PAH), and hypoxia indu-
cible factors (HIF) are the key component of the cellular
response to hypoxia.4 HIFs are heterodimeric transcrip-
tion factors composed of two subunits, a stable HIF1
and one of three oxygen-sensitive subunits HIF1a,
HIF2a, or HIF3a.4
HIFs have been associated with lung development and
PH.5 In humans, genome-wide studies showed a positive
correlation of HIF2a with adaptation to hypobaric hypoxia
in Tibetan highlanders.6,7 In rodents, both Hif1a and Hif2a
appeared to modulate hypoxia-induced PH in gene ablation
studies.5–12 Two reports described that endothelial-speciﬁc
ablation of prolyl-4-hydroxylase 2 (PHD2), which targets
HIFs for degradation by hydroxylating proline residues
in HIF2a under normoxic conditions, results in a HIF2a-
dependent adult PAH.10,11 Using an endothelial-speciﬁc
inactivation of HIF2a, Cowburn et al. showed that HIF2a
is involved in hypoxia-induced PAH.12 Since PAH is diﬀer-
ent from PHN, we examined HIF2a protein expression in a
developmental series of normal lung tissue, as well as in the
lungs of a cohort of CDH patients and patients with idio-
pathic PH.
Materials and methods
Human lung tissue collection
With the approval of the Erasmus MC Medical Ethical
Committee and the informed consent of parents, lung
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tissue was obtained from the archives of the Department of
Pathology, Erasmus MC (Rotterdam).
Immunohistochemistry
Tissue micro arrays were constructed as described.13
Paraﬃn embedded lung material was sectioned, blocked,
and incubated overnight at 4C (HIF2a, Genetex). The
Envision kit (Dako) was used and images were taken with
a charge-coupled device camera attached to an Olympus
BX41 microscope.
Results
HIF2a was expressed in half of the fetal lungs that were
analyzed at 15–36 weeks of gestation. In addition, lungs of
neonates born after week 37 were also positive for HIF2a
(Fig. 1a). HIF2a was localized in the nucleus of proximal
and distal airway epithelial cells and alveolar epithelial cells
(Fig. 1a, arrowheads). Hif2a is also highly expressed in
alveolar type II cells in lungs as we and others have shown
before in mouse lungs.9,14
Next, we analyzed the expression of HIF2a in lungs from
a cohort of CDH patients of diﬀerent gestational ages until
Fig. 1. (a) Representative images of HIF2a protein expression in lungs of two independent control (left) and two CDH patients (right) at three
different gestational ages (weeks 15–23, weeks 24–36, and born after week 37). HIF2a is expressed in half of the control lungs tested, although
some expression is observed in the epithelial cells of the airways (arrowheads). In contrast, HIF2a is expressed in all examined lungs of the CDH
patients, in both epithelial cells (arrowheads) and endothelial cells (arrows). (b) HIF2a is absent in age-matched control lungs, but prominently
expressed in the lungs of some cases of PHN. Two representative images are shown for the control lungs and six images of PHN cases. HIF2a is
expressed in alveolar type II cells (arrowheads) and in endothelial cells (arrows). Scale bar: 100 mm.
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birth. HIF2a is prominently present in all CDH cases ana-
lyzed, contrasting the expression of HIF2a in normal, unaf-
fected lungs (Fig. 1a, Table 1). The sites of HIF2a
expression were in both alveolar epithelial cells (Fig. 1a,
arrowheads) and all endothelial cells of the blood vessels
(Fig. 1a, arrows). Moreover, in some CDH lungs, the level
of HIF2a appeared very high as indicated by the intense
staining (Fig. 1).
We also analyzed 11 lungs of neonates with idiopathic
PH and age-matched controls (Fig. 1b). In the neonatal
control human lung, only few cells are positive for HIF2a
(Fig. 1b, control). Clear staining patterns were observed in
the endothelial cells of the vessels of patients with PHN
(Fig. 1b, arrows) and in alveolar epithelial cells (Fig. 1b,
arrowheads), although not all PHN cases expressed HIF2a
(Fig. 1b). Our data suggest that expression of HIF2a is
maintained in some of the clinical cases of PH, supporting
the relative hypoxia of these patients. Finally, we also ana-
lyzed the expression of one of the HIF2a targets, VEGF,
and found comparable numbers of positive samples as for
the HIF2a staining (Table 1).
Discussion
Previously, we showed a gradual increase of HIF2a messen-
ger RNA (mRNA) during gestation, but no diﬀerences were
detected in expression levels between CDH patients and
controls.15,16 Here, we report an increased expression of
HIF2a protein in CDH patients compared to controls.
Even before birth, we found signiﬁcantly higher expression
of HIF2a in CDH patients. Our data suggest that high levels
of HIF2a correlate with PHN and CDH-associated PH.
Since prolonged exposure to hypoxia results in PH,5 and
the lungs of patients with PH are under constant hypoxic
conditions, it may result in elevated levels of HIF2a.
Although all CDH cases tested were clearly positive for
HIF2a, not all cases of PHN expressed high levels of
HIF2a. This most likely reﬂects the patient variability and
the heterogeneity of PHN.
In all fetal CDH cases, HIF2a was expressed in the lung
and at much higher levels than controls. Moreover, HIF2a
is also highly expressed in the lungs of patients suﬀering
from PHN. This suggests that early in gestation, the lungs
of CDH patients are already intrinsically diﬀerent from
control lungs, and high levels of HIF2a may contribute to
postnatal PH, which develops in a signiﬁcant number of
patients with CDH after birth.
Prolonged hypoxia, which is also observed in PHN
patients, results in structural changes of the pulmonary vas-
culature characterized by a thickening of the vascular wall
of small pulmonary arteries leading to an increased vascular
resistance and a worsening of gas exchange.2 We recently
showed that the vascular smooth muscle cells in the develop-
ing CDH lung had a diﬀerent expression pattern of con-
tractile components compared to control lungs, suggesting
that these cells prematurely diﬀerentiate.17 Furthermore, the
expression of VEGF-A mRNA was increased in the lungs
from CDH patients at the canalicular stage, while a signiﬁ-
cant decrease in the expression of VEGF-A mRNA was
observed in the alveolar stage of lung development in
CDH patients. However, the spatial distribution of
VEGF-A was not diﬀerent between control and CDH
lungs.16,18 Here, we report that HIF2a is expressed in
more CDH lungs than in control lungs, and that the expres-
sion of VEGF appears to correlate with HIF2a expression.
The site of expression does not diﬀer between control and
CDH lungs, as previously described. Additionally, we pre-
viously showed that a signiﬁcant increase in Hif2a in epithe-
lial alveolar type II cells did not induce an increased
expression of Vegf-A.14
Although the mechanisms of HIF2a activity and its role
in the development of PH are still incompletely understood,
it may be a putative target for future therapies. In this
respect, it is interesting to investigate the potential of the
Hif2a-speciﬁc competitor, FM19G11.19
In summary, we showed high expression levels of HIF2a
in the lungs of all CDH patients at diﬀerent gestational ages
and after birth, while only half of the age-matched controls
showed expression of HIF2a. From these results, we suggest
that HIF2a is associated with the development of PH in
CDH, and possibly also with PHN.
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Table 1. CDH patient characteristics and the age-matched control lungs.
Developmental
stage
Gestational
age (weeks) Postnatal age Birth weight (g)
HIF2a-positive
(n/total n)
VEGF-positive
(n/total n)
Control Premature 31.5 (15–36) 1 h (0–24 h) 2000 (57–2700) 5/9 5/9
Term 39.5 (38–41) 36 h (1 h–1 week) 3220 (2490–3950) 4/8 9/11
CDH Premature 31.5 (15–36) 1 h (0–48 h) 1032 (30–2515) 7/7 6/6
Term 39 (37–40) 7 h (1 h–3 days) 2835 (2000–3800) 6/6 9/11
Indicated are the average age in weeks, the average postnatal age, birth weight, and the number of HIF2a-positive and VEGF-positive samples per total samples
tested.
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